Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Ventricular Tachycardia Ablation: Meta-analysis of Randomised Trials
Author(s): Rohin K Reddy , James P Howard , Yousif Ahmad , et al Added: 2 years ago

Electrophysiology & Arrhythmia
Dynamic Voltage Mapping of Ventricular Tachycardia Substrate
Author(s): Mark T Mills , Peter Calvert , Justin Chiong , et al Added: 1 year ago

Electrophysiology & Arrhythmia
Ablation Beats Sotalol for VT in VANISH2 Substudy
Added: 3 days ago Source:  Arrhythmia Academy
A new substudy of the VANISH2 trial suggests that for patients with prior myocardial infarction and ventricular tachycardia (VT) who are eligible for sotalol, catheter ablation leads to better outcomes than antiarrhythmic drug (AAD) therapy.¹ For patients eligible only for amiodarone, efficacy was comparable, but amiodarone was associated with a significant increase in adverse events… View more

Electrophysiology & Arrhythmia

MI/ACS
Pulsed Field Ablation for Ventricular Arrhythmias: Current Evidence
Author(s): Serge Boveda , Andrea Sarkozy Added: 4 weeks ago
In the latest episode of Arrhythmia Academy’s Journal Club, Dr Serge Boveda (Clinic Pasteur, FR) is joined by Professor Andrea Sarkozy (Brussels South University Hospital, BE) to explore the evolving role of pulsed field ablation (PFA) in the treatment of ventricular arrhythmias.The discussion focuses on the potential of PFA as a novel energy source in the ventricle, examining its ability to… View more

Electrophysiology & Arrhythmia
Functional Substrate Mapping
Author(s): Jaffar Al-Sheikhli , Patrick Tran , Rafaella Siang , et al Added: 1 year ago

Electrophysiology & Arrhythmia
Ablation vs Drugs for VT: Insights from VANISH2
Added: 2 weeks ago Source:  Radcliffe Cardiology
A prespecified substudy of the VANISH2 trial suggests first-line catheter ablation is superior to sotalol for reducing arrhythmia events in eligible patients with ischaemic cardiomyopathy and ventricular tachycardia (VT).¹ In patients ineligible for sotalol, ablation showed comparable efficacy to amiodarone but with a markedly better long-term safety profile.MethodologyThe VANISH2 (Ventricular… View more

Electrophysiology & Arrhythmia

Heart Failure
Ventricular Tachycardia After Cardioversion
Author(s): Eiad Habib , Mahmoud Abdelnabi , Ramzi Ibrahim , et al Added: 2 months ago

Electrophysiology & Arrhythmia

Heart Failure
EHRA 25: The European Affera Ventricular Arrhythmia Ablation Registry
Author(s): Frédéric Sacher Added: 10 months ago
EHRA 2025 - Positive safety results of the Affera mapping and ablation system for the treatment of ventricular arrhythmias (VA) show a 6% rate of major complication.Dr Frédéric Sacher (IHU Liryc, Bordeaux, FR) joins us on-site at EHRA Congress 2025 to discuss safety results from the European Affera Ventricular Arrhythmia Ablation Registry, investigating VA ablation with the Affera Sphere-9… View more

Electrophysiology & Arrhythmia
Idiopathic Annular Ventricular Arrhythmias
Author(s): Zachary T Yoneda , William G Stevenson Added: 1 year ago

Electrophysiology & Arrhythmia
HRS 25: FIH VCAS Trial
Author(s): Vivek Reddy Added: 9 months ago
HRS 25 - First-in-human data from the FIH VCAS trial suggests the FieldForce Ablation system can effectively create transmural ablation lesions in patients with scar-related ventricular tachycardia (VT), with an 80% freedom from VT and ventricular fibrillation rate at 6 months.We are joined by Dr Vivek Reddy (Mount Sinai Hospital, New York, US) to discuss the findings from the prospective, first… View more

Electrophysiology & Arrhythmia